The role of the Acute Cystitis Symptom Score questionnaire for research and antimicrobial stewardship. Validation of the Hungarian version

András Magyar, Jakhongir Alidjanov, Adrian Pilatz, Károly Nagy, Vinodh Kumar Adithyaa Arthanareeswaran, Sándor Póth, András Bécsi, Florian M E Wagenlehner, Kurt G Naber, Péter Tenke, Béla Köves, András Magyar, Jakhongir Alidjanov, Adrian Pilatz, Károly Nagy, Vinodh Kumar Adithyaa Arthanareeswaran, Sándor Póth, András Bécsi, Florian M E Wagenlehner, Kurt G Naber, Péter Tenke, Béla Köves

Abstract

Introduction: The Acute Cystitis Symptom Score (ACSS) is a new self-reporting tool to evaluate the symptoms of uncomplicated acute cystitis (AC) in women. The linguistic and clinical validation process of the Hungarian version used in this study may serve as a guide for the validation of the ACSS in other languages.

Material and methods: In this prospective cohort study, women with AC (Patients) and those without (Controls) filled in the Hungarian ACSS version, during their visits to physician's office. Statistical analysis included ordinary descriptive values, calculation of reliability, validity, discriminative ability, responsiveness (sensitivity, specificity) and comparative analysis.

Results: Thirty-one patients were recruited for validation along with 37 controls. Statistical analyses resulted in excellent values of internal consistency, discriminative ability and validity for diagnosis of AC. At the cut-off at a score of 6 in the 'typical' domain, positive and negative predictive values were 97% and 92%, sensitivity and specificity were 90% and 97%, respectively.

Conclusions: The ACSS has demonstrated benefits for diagnosis and patient-reported outcome assessment. It is objective, fast, and cost-effective, and may help to easily confirm the accurate diagnosis of AC. Therefore, it may be especially important for clinical and epidemiological studies on AC in women.

Keywords: cystitis; female; follow-up; genitourinary tract infection; pain; questionnaire.

Figures

Figure 1
Figure 1
Mean score comparison of typical symptoms between patients and controls.
Figure 2
Figure 2
Sum scores (box-and-whisker plots) of ‘typical’ symptoms among patients and controls with cut-off line.

References

    1. Foxman B, Brown P. Epidemiology of urinary tract infections: transmission and risk factors, incidence, and costs. Infect Dis Clin North Am. 2003;17:227–241.
    1. Bonkat G PR, Bartoletti R, Bruyère F, et al. EAU Guidelines London. London: European Association of Urology; 2017. Urological Infections; pp. 857–920.
    1. Allerberger F, Gareis R, Jindrak V, Struelens MJ. Antibiotic stewardship implementation in the EU: the way forward. Expert Rev Anti Infect Ther. 2009;7:1175–1183.
    1. Lesprit P, Brun-Buisson C. Hospital antibiotic stewardship. Curr Opin Infect Dis. 2008;21:344–349.
    1. Nilholm H, Holmstrand L, Ahl J, et al. An audit-based, infectious disease specialist-guided antimicrobial stewardship program profoundly reduced antibiotic use without negatively affecting patient outcomes. Open Forum Infect Dis. 2015;2:ofv042.
    1. Cek M, Tandogdu Z, Naber K, et al. Antibiotic prophylaxis in urology departments, 2005-2010. Eur Urol. 2013;63:386–394.
    1. Davey P, Brown E, Charani E, et al. Interventions to improve antibiotic prescribing practices for hospital inpatients. Cochrane Database Syst Rev. 2013;4:CD003543.
    1. Wagenlehner FM, Bartoletti R, Cek M, et al. Antibiotic stewardship: a call for action by the urologic community. Eur Urol. 2013;64:358–360.
    1. Wagenlehner FM, Naber KG. Treatment of bacterial urinary tract infections: presence and future. Eur Urol. 2006;49:235–244.
    1. Beerepoot MA, Geerlings SE, van Haarst EP, van Charante NM, ter Riet G. Nonantibiotic prophylaxis for recurrent urinary tract infections: a systematic review and meta-analysis of randomized controlled trials. J Urol. 2013;190:1981–1989.
    1. Gagyor I, Bleidorn J, Kochen MM, Schmiemann G, Wegscheider K, Hummers-Pradier E. Ibuprofen versus fosfomycin for uncomplicated urinary tract infection in women: randomised controlled trial. BMJ. 2015;351:h6544.
    1. Alidjanov JF, Abdufattaev UA, Makhsudov SA, et al. New self-reporting questionnaire to assess urinary tract infections and differential diagnosis: acute cystitis symptom score. Urol Int. 2014;92:230–236.
    1. Alidjanov JF, Abdufattaev UA, Makhsudov SA, et al. The acute cystitis symptom score for patient- reported outcome assessment. Urol Int. 2016;97:402–409.
    1. Alidjanov JF, Pilatz A, Abdufattaev UA, et al. German validation of the acute cystitis symptom score. Urologe A. 2015;54:1269–1276.
    1. Alidjanov JF PA, Abdufattaev UA, et al. Preliminary Clinical validation of the english language version of the acute cystitis symptom score. BMC Urol. 2016 [Article in press]
    1. Alidjanov JF, Pilatz A, Abdufattaev UA, et al. New questionnaire for the German validation of the Acute Cystitis Symptom Score Urologe. 2017;56:364–366.
    1. Acquadro C CK, Girourdet C, Mear I. Linguistic Validation Manual for Patient-Reported Outcomes (PRO) Instruments. Qual Life Res. 2005;14:1791–1792.
    1. Alidjanov JF, Abdufattaev UA, Makhmudov D, et al. Development and clinical testing of the Russian version of the Acute Cystitis Symptom Score - ACSS. Urologiia. 2014;6:14–22.
    1. Alidjanov JF AO, Basitkhanov BT, Abdufattaev UA, et al. Certificate of Authorship: ”e-USQOLAT: The Web-Based Online Platform for Diagnosis of Lower Urinary Tract Infections in Women”. 2017. .
    1. Cronbach LJ. A case study of the split-half reliability coefficient. J Educ Psychol. 1946;37:473–480.
    1. Cronbach LJ. Test reliability; its meaning and determination. Psychometrika. 1947;12:1–16.
    1. Shapiro SS WM. An analysis of variance test for normality (complete samples) Biometrika. 1965;52:591–611.
    1. Mann HB DW. On a Test of Whether One of Two Random Variables is Stochastically Larger Than the Other. Ann Math Statist. 1947;18:50–60.
    1. Student The probable error of a mean. Biometrika. 1908;1908:1–25.
    1. The Acute Cystitis Symptom Score website (2017.08.27).
    1. Vik I, Bollestad M, Grude N, et al. Ibuprofen versus mecillinam for uncomplicated cystitis - a randomized controlled trial study protocol. BMC Infect Dis. 2014;14:693.
    1. Barry MJ, Fowler FJ Jr, O'Leary MP, et al. The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association. J Urol. 1992;148:1549–1557.
    1. Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A. The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology. 1997;49:822–830.
    1. Kranz J, Schmidt S, Lebert C, et al. Epidemiology, diagnostics, therapy, prevention and management of uncomplicated bacterial outpatient acquired urinary tract infections in adult patients: Update 2017 of the interdisciplinary AWMF S3 guideline. Urologe A. 2017;56:746–758.

Source: PubMed

스폰서 및 공동 작업자

건강 상태

약물 개입

3
구독하다